News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Sarepta Therapeutics, Inc.
NEWS
JOBS
IN THE PRESS
NEWS
BioMidwest
3 Biotech Stocks That Exploded in 2017
Rick Duprey, writing for The Motley Fool, takes a look at three biotech stocks that have quadrupled this year.
December 5, 2017
·
2 min read
·
Mark Terry
Genetown
Sarepta Jumps Despite DMD Safety Issues in FDA Database
October 3, 2017
·
2 min read
Policy
Sarepta’s Exondys 51 Saga Continues as More Details About FDA’s Criticism Uncovered
August 22, 2017
·
3 min read
Policy
FDA Docs Reveal CDER Chief Skirted Procedures Approving Sarepta’s Controversial Drug Eteplirsen
August 3, 2017
·
1 min read
Deals
New Sarepta CEO’s M&A Experience Sparks Sale Speculation
June 30, 2017
·
3 min read
Business
Sarepta Taps Allergan Alum as New CEO
June 29, 2017
·
2 min read
Policy
Journalist Sues FDA for Documents Related to Sarepta’s DMD Drug
May 26, 2017
·
4 min read
Genetown
Can Sarepta Continue To Live Up To The DMD Hype?
May 8, 2017
·
1 min read
Deals
Sarepta Tests Biotech’s CEO Vacuum Hypothesis
May 2, 2017
·
1 min read
AWARDS
JOBS
Currently, there are no jobs for this company on BioSpace
Browse all jobs
here
Oops!
There was an issue retrieving the jobs list. Please reload the page to view more jobs.
Title
Location
Company Name
Desc
View details
IN THE PRESS
Press Releases
Sarepta Announces Approval to Begin ENDEAVOR Cohort 8 to Evaluate Enhanced Immunosuppression Regimen as Part of ELEVIDYS Gene Therapy for Non-Ambulant Individuals with Duchenne
November 26, 2025
·
12 min read
Press Releases
Arrowhead Pharmaceuticals Earns $200 Million Milestone Payment from Sarepta Therapeutics
November 24, 2025
·
4 min read
Press Releases
Sarepta Provides Progress Update for SRP-1003, its Investigational siRNA treatment for Myotonic Dystrophy Type 1
November 24, 2025
·
4 min read
Press Releases
FDA Approves New Safety Warning and Revised Indication that Limits Use for Elevidys Following Reports of Fatal Liver Injury
November 17, 2025
·
3 min read
Press Releases
Sarepta Announces FDA’s Approval of Updated ELEVIDYS Prescribing Information
November 17, 2025
·
10 min read
Press Releases
Sarepta Therapeutics Announces Third Quarter 2025 Financial Results and Recent Corporate Developments, Including Completion of Its Confirmatory Study, ESSENCE
November 3, 2025
·
19 min read
Press Releases
Sarepta Therapeutics to Announce Third Quarter 2025 Financial Results
October 28, 2025
·
1 min read
Press Releases
Sarepta Therapeutics to Present New Data from its Neuromuscular Portfolio at 2025 World Muscle Society Congress
October 6, 2025
·
16 min read
Press Releases
Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - September 30, 2025
October 1, 2025
·
1 min read
Press Releases
Sarepta Therapeutics Announces Recipients of Route 79, The Duchenne Scholarship Program, for the 2025-2026 Academic Year
September 8, 2025
·
4 min read
